ACE2 and acute kidney injury: SARS-CoV-2-associated acute kidney injury.Combination therapy using Remdesivir with recombinant soluble ACE2 (high/low dose) reduces virus entry and replication.Human recombinant soluble ACE2 inhibits SARS-CoV-2 infection and mitigates propagation.